An evaluation of hemoglobin A1c test ordering patterns in a primary care setting

Laboratory Medicine

Volumn 43, Issue 2, 2012, Pages 1-5

  Salinas, Maria ^a   Lopez Garrigós, Maite ^a   Pomares, Francisco ^a   Ruiz Palomar, Jose Manuel ^a   Santo Quiles, Ana ^a   López Penabad, Luis ^a   Asencio, Alberto ^b   Uris, Joaquin ^b  

^a University Hospital of San Juan   (Puerto Rico)

^b UNIVERSITY OF ALICANTE   (Spain)

Author keywords

Biological markers; Efficiency and cost analysis; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; CALCULATION; CLINICAL EVALUATION; CROSS-SECTIONAL STUDY; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; STATISTICAL SIGNIFICANCE;

EID: 84869457961     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LMB520NCHEHKTXVR     Document Type: Article

References (21)

1. Sacks DB, Bruns DE, Goldstein DE, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2002;48:436-472
2. 1c-A marker for complications of type 2 diabetes: The experience from the U.K. Prospective Diabetes Study (UKPDS). Clin Chem Lab Med. 2003;41:1182-1190
3. Goldstein DE, Little RR, Lorenz RA, et al. Test of glycemia in diabetes. Diabetes Care. 2004;27:1761-1773
4. van Walraven C, Raymond M. Population-based study of repeat laboratory testing. Clin Chem. 2003;49:1997-2005
5. 1c screening for undiagnosed diabetes in New Zealand. Diabetes Metab Res Rev. 2005;21:65-70
6. 1c assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327-1334
7. 1c and ABCD of glycaemia management in type 2 diabetes: A physician's personalized approach. Diabetes Metab Res Rev. 2010;26:239-244
8. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62-S69
9. 1c measurement: The American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care. 2007;30:2399-2400
10. Catalá MJ, Catalá M, Girbés J, et al. Prevalencia de diabetes y síndrome metabólico en la Comunidad Valenciana. "Estudio Valencia." In Plan de Diabetes de la Comunidad Valenciana 2006-2010. Generalitat Valenciana, Conselleria de Sanitat 2006
11. 1c in predicting diabetes risk. J Gen Intern Med. 2004;19:1175-1180
12. 1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med. 2007;120:720-727
13. 1c is effective for the prediction of type 2 diabetes: The Kansai Healthcare Study. Diabetes Care. 2009;32:644-646
14. Wilson SE, Lipscombe LL, Rosella LC, et al. Trends in laboratory testing for diabetes in Ontario, Canada, 1995-2005: A population-based study. BMC Health Serv Res. 2009;9:41
15. van Wijk MA, van der Lei J, Mosseveld M, et al. Compliance of general practitioners with a guideline-based decision support system for ordering blood tests. Clin Chem. 2002;48:55-60.
16. Poley MJ, Edelenbos KI, Mosseveld M, et al. Cost consequences of implementing an electronic decision support system for ordering laboratory tests in primary care: Evidence from a controlled prospective study in The Netherlands. Clin Chem. 2007;53:213-219.
17. 1c to screen for diabetes. J Diabetes Sci Technol. 2009;3:411-417.
18. Benito-López P, García-Mayor R, Puig-Domingo M, et al.[Pathological characteristics of patients with diabetes mellitus type 2, in Spanish Primary Care]. [Spanish]. Rev Clin Esp. 2004;204:18-24.
19. Mengual L, Roura P, Serra M, et al. Multifactorial control and treatment intensity of type-2 diabetes in primary care settings in Catalonia. Cardiovasc Diabetol. 2010;9:14
20. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care. 2004;27(suppl 1):S11-S14.
21. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33(suppl 1):S11-S61.